Skip to main content
. 2012 Nov 2;2:190–195. doi: 10.1016/j.rinim.2012.10.003

Fig. 1.

Fig. 1

Median serum levels and range of (A) CA 125, (B) HGF, (C) IL-8, (D) PAI-1, (E) leptin, (F) resistin and (G) adiponectin levels in patients with carcinoma, borderline, and benign tumors of the ovary (N = 113). *: comparison carcinomas/benign; ‡: comparison carcinomas/borderline; †: comparison borderline/benign, significant differences, p<0.05.